“The key to successful physician practice management is self-control on the sell-side and being reasonable about compensation,” observes John Tiedmann, a managing director at Physician Growth Partners, in this conversation with host Geoff Cockrell. With over 70
Continue Reading The Compensation Mistake PPM Investors Regret, With John Tiedmann
Winning the Insurance Game in Healthcare Transactions, With Hannah Ellithorpe
“Underwriters are more willing to take creative approaches now than they would have been in the last couple of years,” observes Hannah Ellithorpe, executive director and head of healthcare and life sciences at Atlantic Global Risk. The former
Continue Reading Winning the Insurance Game in Healthcare Transactions, With Hannah EllithorpeCan AI Level the Playing Field in Dental Marketing? With Ryan Torresan
“The hot topic right now is how AI fits into dental marketing,” says Ryan Torresan, chief marketing officer at Peak Dental Services. With 14 years of experience across multiple dental service organizations (DSOs), Ryan predicts AI will be
Continue Reading Can AI Level the Playing Field in Dental Marketing? With Ryan TorresanInvestment Opportunities in Behavioral Health, With Adam Abramowitz
The behavioral health sector encompasses segments from substance abuse treatment to autism therapy — a breadth of opportunity that Adam Abramowitz, managing director at Intrepid Investment Bankers, explores with McGuireWoods partner and host Geoff Cockrell. Adam details
Continue Reading Investment Opportunities in Behavioral Health, With Adam AbramowitzHas the Reset Really Hurt Healthcare M&A? With Diwakar Sinha
Pointing to renewed optimism in healthcare transactions, Diwakar Sinha suggests that “2025 looks very promising and should be a very successful year in the M&A space.” As founder and CEO of Polaris Healthcare Partners, Diwakar shares insights on the
Continue Reading Has the Reset Really Hurt Healthcare M&A? With Diwakar SinhaDespite Complexities, Healthcare PE Opportunities Abound, With Max Reiboldt
Max Reiboldt visits McGuireWoods partner and host Geoff Cockrell about the future of private equity in healthcare, particularly in provider services. Chairman of the Coker Group, a leading sell-side investment bank in healthcare transactions, Max is the lead
Continue Reading Despite Complexities, Healthcare PE Opportunities Abound, With Max ReiboldtHow Matt Stekier Drives Value Creation in Private Equity Healthcare Investments
McGuireWoods partner and host Geoff Cockrell, invites Matt Stekier, a principal at Plante Moran’s management consulting group, to discuss challenges in the medical devices and product sector.
Matt covers supply chain vulnerabilities, inventory management issues and post-acquisition
Continue Reading How Matt Stekier Drives Value Creation in Private Equity Healthcare InvestmentsWhat Optometry Needs to Know to Remain Competitive, With Ben Chudner
The optometry market suffers from a staffing shortage but benefits from an aging population — a balance of headwinds and tailwinds that Dr. Ben Chudner discusses with McGuireWoods partner and host Geoff Cockrell.
The chief medical officer at
Continue Reading What Optometry Needs to Know to Remain Competitive, With Ben ChudnerInvestment Outlook for Three Healthcare Sectors, With Jeremy Johnson
McGuireWoods partner and host Geoff Cockrell invites Jeremy Johnson, senior managing director at Bourne Partners investment bank, for a discussion about business and investment prospects in three healthcare sectors: pharma services, provider services and payor services.
The pharma services
Continue Reading Investment Outlook for Three Healthcare Sectors, With Jeremy JohnsonHealthcare & Life Sciences Private Equity Deal Tracker: InTandem Invests in Clinilabs
InTandem Capital Partners has announced it has completed an investment in Clinilabs.
Clinilabs, founded in 2000 and based in Eatontown, New Jersey, is a contract research organization focused on central nervous system drug, device and technology development.
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: InTandem Invests in Clinilabs